Deutsche Bank AG increased its stake in Nano-X Imaging Ltd. (NASDAQ:NNOX – Free Report) by 38.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 52,499 shares of the company’s stock after purchasing an additional 14,617 shares during the quarter. Deutsche Bank AG’s holdings in Nano-X Imaging were worth $378,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of NNOX. US Bancorp DE increased its stake in shares of Nano-X Imaging by 388.7% in the 4th quarter. US Bancorp DE now owns 3,470 shares of the company’s stock valued at $25,000 after acquiring an additional 2,760 shares in the last quarter. Quadrant Capital Group LLC grew its position in Nano-X Imaging by 464.9% in the 4th quarter. Quadrant Capital Group LLC now owns 7,016 shares of the company’s stock valued at $51,000 after purchasing an additional 5,774 shares during the period. Quantum Private Wealth LLC acquired a new stake in Nano-X Imaging in the 4th quarter valued at $72,000. Signaturefd LLC grew its position in Nano-X Imaging by 164.6% in the 4th quarter. Signaturefd LLC now owns 10,391 shares of the company’s stock valued at $75,000 after purchasing an additional 6,464 shares during the period. Finally, Bayesian Capital Management LP acquired a new stake in Nano-X Imaging in the 4th quarter valued at $81,000. Institutional investors own 21.49% of the company’s stock.
Nano-X Imaging Trading Down 2.7%
NASDAQ NNOX opened at $5.11 on Friday. The company has a fifty day simple moving average of $5.03 and a 200 day simple moving average of $6.29. Nano-X Imaging Ltd. has a 12-month low of $3.75 and a 12-month high of $11.00. The company has a market cap of $295.25 million, a P/E ratio of -6.01 and a beta of 2.03.
Analyst Ratings Changes
Several analysts recently issued reports on NNOX shares. Cantor Fitzgerald reduced their price target on shares of Nano-X Imaging from $12.00 to $9.00 and set an “overweight” rating for the company in a research report on Tuesday, April 1st. Alliance Global Partners reissued a “buy” rating on shares of Nano-X Imaging in a research report on Thursday, May 22nd. Finally, D. Boral Capital reduced their price target on shares of Nano-X Imaging from $15.00 to $10.00 and set a “buy” rating for the company in a research report on Friday, May 23rd.
Read Our Latest Stock Analysis on Nano-X Imaging
Nano-X Imaging Company Profile
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Featured Stories
- Five stocks we like better than Nano-X Imaging
- Overbought Stocks Explained: Should You Trade Them?
- Nike’s Amazon Expansion Could Signal a Turnaround in 2025
- How to trade using analyst ratings
- Intel’s Turnaround May Be the Best Bet No One’s Watching
- What is a penny stock? A comprehensive guide
- 3 Defense Stocks That Will Profit From a Golden Dome
Want to see what other hedge funds are holding NNOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nano-X Imaging Ltd. (NASDAQ:NNOX – Free Report).
Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.